Vaxxed – the Vaccines Contain Aborted Human Fetus Cells

#

Featured Image – Dr Self Love Lance O’Sullivan with serial Jewish pedophile – John Key. Can we say that? John does claim to be Jewish and was clearly a serial pedophile. 

…..

Just can’t help ourselves.

Under the new Republic, Media Whores will probably keep blogging anyway.

Took a quick look at the NZ govt vaccines website this morning and sure enough, they use aborted human baby fetus cells. Among other poisonous horrors including cow and monkey organ derivatives.

They claim you should not worry however, they only use aborted baby fetuses from the 1960’s when the ‘technology’ was first discovered – they now grow those same aborted baby cells in a lab and use those. So you are kind of just being injected with the lab grown ‘family’ of those first aborted babies. Please be assured that these aborted babies receive three square meals a day while being harvested for your vaccines…and make up.

Along with some aborted cow and monkey type cells. And Formaldehyde.

To keep you healthy.

“Oh but they need the aborted babies because E=mc2….” – shut the fk up. Don’t be retarded.

The Tetanus vaccine is the one they get most people with – along with the annual flu vaccines.

Most of the additives take a few years to kick in – so you do not know what to blame as you grow sick and die.

Some say many of the top vaccine doctors overseas are being bribed for pedophilia – the usual modus operandi for these types. But we have seen no direct evidence of this here.

John-Key-Abuse

One thing is for – Dr Lance O’Self Love Sullivan is a professional lunatic.

Please be assured that the aborted human babies these days are used for other purposes – mostly in your food (so called natural and artificial “flavours”) and make ups.

http://www.immune.org.nz/sites/default/files/resources/Written%20Resources/ConcernIngredientsAnimalImac20170825V01Final.pdf

Human cell lines Attitudes and practices around abortion were different in the 1960s compared with the present day, but even then pregnancies were not terminated for the advancement of science. Pregnancies were terminated to support the well-being of women and their families. Cells were taken from what, at that time, was considered to be the by-product of an abortion. No new fetal tissue has been required since the 1960s. Babies are not being aborted in order to produce vaccines. The cells used now are not the originally harvested cells, they are descendants of those cells. Perpetual human cell lines from the 1960s are used to grow the hepatitis A, rubella and varicella (chickenpox) viruses for vaccines. » The WI-38 cell line is used to grow rubella virus in M-M-R II. The original cells came from a fetus in 1961 after an abortion because the parents felt they had too many children. » The MRC-5 cell line is used to grow rubella virus in Priorix, varicella (chickenpox) virus in Varilrix® and hepatitis A virus in Havrix® Junior and Havrix® vaccines. The original cells came from a fetus in 1966 after an abortion because the mother had psychiatric problems.

Human cell lines …continued The original rubella virus used in the M-M-R II and Priorix vaccines came from a fetus in 1964 after an abortion because the mother had been infected with the rubella virus. Perspective of major religions Catholicism The Vatican published moral reflections on vaccines prepared from cells derived from an aborted human fetus in June 2005. They said that, where there is no alternative vaccine, the use of vaccines derived from an aborted human fetus should not be misinterpreted as approving their production, marketing and use. They considered use of the vaccine is passive material cooperation and morally justified to avoid a serious risk, not only for one’s own children but for the health of the population as a whole, especially pregnant women. They deemed that use of the vaccine occurs in a context of moral coercion of parents who are forced to act against their conscience.

Human blood products Human albumin Human albumin, either engineered from yeast cells or derived from human blood, is used as a stabiliser in some vaccines. Human albumin used in the M-M-R II vaccine is not derived from liver or blood products. It is engineered from yeast cells to imitate real human albumin. Human albumin is no longer use

Porcine circovirus In March 2010 fragments of porcine circovirus (PCV) DNA were found to have been in both Rotarix and RotaTeq rotavirus vaccines since they were developed. The World Health Organization (WHO), European Medicines Agency, and U.S. Food and Drug Administration (FDA) reviewed available information and concluded that both vaccines have been shown to be safe and effective in preventing severe diarrhoea and there was no evidence of PCV disease in children who had already received the vaccines. Porcine circoviruses are also found in pork food products. They have been detected in adult faeces without any evidence of having caused harm or illness in humans. National Immunisation Schedule vaccines and animal derived products Table 1 on this page and the following page shows the vaccines on the National Immunisation Schedule that have had exposure to animal derived products during manufacture. Some finished vaccines that were exposed to animal derived products during manufacture have no residuals from animal derived products, others may have an amount so small it is presumed present but cannot be measured, and others an amount that can be measured perhaps as a trace, parts per million or parts per billion. Vaccine purification at the end of the manufacturing process ensures that the final vaccine has no harmful components and a minimal amount of any ingredient that was part of the manufacturing process, but is no longer needed for the vaccine to work.

Table 1. National Immunisation Schedule vaccines exposure to animal derived products during manufacture Vaccine Disease(s) Exposure to animal derived products Act-HIB Haemophilus influenzae type b (Hib) » Bovine serum albumin or fetal calf serum used as a nutritional component in some growth mediums. ADT Booster Tetanus/diphtheria » Bovine serum albumin or fetal calf serum used as a nutritional component in some growth mediums. Boostrix Tetanus/diphtheria/ acellular pertussis » Bovine serum albumin or fetal calf serum used as a nutritional component in some growth mediums. Havrix Junior Havrix Hepatitis A » MRC-5 cell line derived from a fetus aborted in 1966 is used to grow hepatitis A virus. Hiberix Haemophilus influenzae type b (Hib) » Bovine serum albumin or fetal calf serum used as a nutritional component in some growth mediums. Infanrix-hexa Diphtheria/tetanus/ acellular pertussis/polio/ hepatitis B/Haemophilus influenzae type b (Hib) » Bovine serum albumin or fetal calf serum used as a nutritional component in some growth mediums. » Vero cells derived from monkey kidney cells in 1962 are used to grow polio viruses. Continued .. National Immunisation Schedule vaccines and animal derived products (updated August 2017) Fact sheet August 2017 Table 1. National Immunisation Schedule vaccines exposure to animal derived products during manufacture …continued Vaccine Disease(s) Exposure to animal derived products Infanrix-IPV Diphtheria/tetanus/ acellular pertussis/polio » Calf serum used as a nutritional component in some growth mediums. » Vero cells derived from monkey kidney cells in 1962 are used to grow polio viruses. Influvac Influenza » Embryonated chicken eggs are used to grow influenza viruses. » Egg protein. IPOL Polio » Bovine serum albumin or fetal calf serum used as a nutritional component in some growth mediums. » Vero cells derived from monkey kidney cells in 1962 are used to grow polio viruses. NeisVac-C Meningococcal group C » Bovine serum albumin or fetal calf serum used as a nutritional component in some growth mediums. M-M-R II Priorix Measles, mumps, rubella » Fetal calf serum used as a nutritional component in some growth mediums. » Chicken embryo cells are used to grow the measles and mumps viruses. » Rubella virus came from a fetus aborted in 1964. » WI-38 cell line derived from a fetus aborted in 1961 is used to grow rubella virus on M-M-R II. » MRC-5 cell line derived from a fetus aborted in 1966 is used to grow rubella virus in Priorix. » Gelatin used as a vaccine stabiliser may be bovine or porcine derived. Rotarix RotaTeq Rotavirus » Fetal calf serum used as a nutritional component in some growth mediums. » Vero cells derived from monkey kidney cells in 1962 are used to grow the reassorted rotaviruses. » Porcine-derived material, e.g. trypsin. » Porcine circovirus DNA fragments. Varilrix Varicella (Chickenpox) » MRC-5 cell line derived from a fetus aborted in 1966 is used to grow varicella virus.

http://www.immune.org.nz/sites/default/files/resources/Written%20Resources/ConcernVaccineIngredients20170825V01Final.pdf

Excipients A substance other than the active ingredient included in the manufacturing process or contained in a finished pharmaceutical product. They include: • Preservatives • Stabilisers • Buffers • Surfactants/emulsifiers • Solvents • Residuals • Diluents

Aluminium Salts Aluminium salts have been used as adjuvants for over 80 years. Most commonly these are aluminium hydroxide, aluminium phosphate and potassium aluminium sulphate (alum). Aluminium adjuvants work by helping to retain the antigen at the injection site long enough for an immune response to be generated and by inducing immune system cells and a range of inflammatory factors to the local injection site to enhance the immune response. Most current inactivated and subunit vaccines use aluminium salts which have an impressive safety record. Additionally, the use of aluminium adjuvants in vaccines generally means that less antigen is required. Some studies have found aluminium containing vaccines to be associated with local reactions and, less often, with the

development of subcutaneous nodules at the injection site. This is particularly so if the injection is given too superficially. Other studies have reported fewer reactions with aluminium containing vaccines than those without, and in some cases, fewer vaccine doses were needed. An individual’s exposure to aluminium from vaccines is far less than that received from a normal diet and environmental exposure. Aluminium is the eighth most abundant element on earth and the most common metallic element. It is found in the blood of all animals including humans, and we are constantly exposed to it. The average daily intake is 10–15mg. Average water has about 0.2mg of aluminium per litre, the hepatitis B vaccine has 0.25mg of aluminium. Aluminium in vaccines is absorbed into the blood and excreted via the kidneys in urine. A recent review of all the available studies of aluminiumcontaining diphtheria, tetanus and pertussis vaccines (either alone or in combination) did not find any evidence that aluminium salts in vaccines cause serious or long-term adverse events. MF59 No vaccines currently used in New Zealand contain the oil-inwater emulsion MF59. It is made using squalene (a hydrocarbon oil) which is common in foods as well as being produced in the body as precursor to cholesterol and steroid hormones. MF59 significantly enhances immune response to a variety of antigens. It is used in some influenza vaccines overseas. A recent review of safety data from five trials using MF59 adjuvanted v.s. non-adjuvanted influenza vaccines in children and adolescents, aged from 6 months to 18 years, did not identify any safety issues. However, mild to moderate injection site and systemic vaccine reactions were more common after a vaccine containing MF59 vaccine than after a non-adjuvanted vaccine. AS03 and AS04 No vaccines currently used in New Zealand contain the AS03 and AS04 adjuvants. AS03 is made with squalene, similar to MF59. It has been used in a pandemic influenza vaccine in Europe. AS04 contains aluminium hydroxide and modified molecules from the Salmonella minnesota bacterium. Theoretical concerns have been raised that these new adjuvants may cause overproduction of inflammatory factors leading to autoimmune disease. However, a large analysis of 68,000 people, some who had received AS04 adjuvanted vaccines and others who had not (controls), concluded that both vaccine recipients and controls had a low rate of autoimmune disorders. Excipients Preservatives Preservatives stop unwanted microbial contamination of vaccines. They have been used in vaccines for many years. Very few serious adverse events have been associated with the use of these preservatives. 2-phenoxyethanol The most commonly used preservative in vaccines is 2-phenoxyethanol. It is also used in cosmetics, eye and ear drops, and baby care products where it is absorbed through skin. 2-phenoxyethanol is excreted by being exhaled and in urine and faeces after being metabolised (broken down). There is little toxicity in humans and some irritation with very high doses in animals.

Excipients continued Phenol Phenol is an aromatic alcohol infrequently used as a preservative in vaccines. Thiomersal No vaccines on the New Zealand Immunisation Schedule contain thiomersal, also called thimerosal. Thiomersal is a mercury derived compound that was used as a preservative in vaccines and other health care products internationally for many years. There is no evidence that thiomersal caused any serious or long-term adverse events. Stabilisers Stabilisers inhibit chemical reactions and prevent components separating or sticking to the vial during transport and storage. Examples of stabilisers include sugars such as lactose and sucrose, amino acids such as glycine and monosodium glutamate (salts of amino acids), proteins such as recombinant human albumin (Recombumin®) derived from baker’s yeast or fetal bovine (cow) serum and gelatin, partially hydrolysed collagen usually of porcine (pig) but can be of bovine origin. Buffers and ionic compounds Buffers serve to resist changes in pH, such as monopotassium phosphate and sodium borate. Ionic compounds adjust tonicity and maintain osmolarity. The most commonly used ionic compound is sodium chloride (table salt). Surfactants Surfactants are a type of emulsifier. They assist particles remain suspended in liquid, preventing settling and clumping by lowering the surface tension of the liquid. An example is polysorbate 80 (Tween 80®), made from sorbitol (sugar alcohol) and oleic acid (omega-9 fatty acid), which is also used in foods such as ice cream. Surfactants are also used in shampoos, toothpastes, inks and fabric softeners. Solvents A solvent is a substance that dissolves another substance, creating a solution. The most common solvent used in everyday living and vaccine manufacture is water. Residuals Residuals are the remaining minute quantities of substances that have been used during the manufacturing or production process of individual vaccines. Residuals depend on the process used, which may have involved cell culture mediums, egg proteins, yeast, antibiotics such as neomycin or streptomycin, or inactivating agents such as formaldehyde. These substances are only present as traces and often measured as parts per million and parts per billion in the final vaccine formulation. Diluents A diluent is a liquid used to dilute a vaccine to the proper concentration immediately prior to administration. This is usually sterile water. Animal derived products Some people have concerns about animal derived products such as gelatin in vaccines. This may be for faith-based reasons or concerns about the safety of animal derived products. More information on animal derived products in vaccines can be found on the Written Resources page on the Immunisation Advisory Centre web site.

Act-HIB Vaccine against Haemophilus influenzae type b (Hib) disease Type: Subunit, polysaccharide conjugate vaccine Vaccine ingredients Gardasil Vaccine against human papillomavirus disease (4-valent) Type: Subunit, recombinant protein vaccine Ingredients Quantity/dose (0.5mL) Function Active substances r-HPV 6 & 18 L1 proteins 20 μg Antigen r-HPV 11 & 16 L1 proteins 40 μg Antigen Adjuvants Aluminium as amorphous aluminium hydroxyphosphate sulphate 225 µg Adjuvant Excipients Culture media including yeast protein Residual Grow human papillomaviruses and yeast Sodium chloride 9.56 mg Adjust tonicity Sodium borate 35 μg Buffer L-histidine 0.78 mg Stabiliser Polysorbate 80 50 μg Surfactant Water for injection Solvent Fact sheet August 2017 page 4 Gardasil 9 Vaccine against human papillomavirus disease (9-valent) Type: Subunit, recombinant protein vaccine Ingredients Quantity/dose (0.5mL) Function Active substances r-HPV 31, 33, 45, 52 & 58 20 μg Antigen r-HPV 6 L1 protein 30 μg Antigen r-HPV 11 & 18 L1 proteins 40 μg Antigen r-HPV 16 L1 protein 60 μg Antigen Adjuvants Aluminium as amorphous aluminium hydroxyphosphate sulphate 500 μg Adjuvant Excipients Culture media including yeast protein Residual Grow human papillomaviruses and yeast Sodium chloride 9.56 mg Adjust tonicity Sodium borate 35 μg Buffer L-histidine 0.78 mg Stabiliser Polysorbate 80 50 μg Surfactant Water for injection Solvent HBvaxPRO Vaccine against hepatitis B disease Type: Subunit, recombinant protein vaccine Ingredients Quantity/dose (0.5mL) Function Active substances Hepatitis B surface antigen 5 μg Antigen Adjuvants Aluminium as amorphous aluminium hydroxyphosphate sulphate 0.25 mg Adjuvant Excipients Culture media including yeast protein Residual Grow hepatitis B viruses and yeast Formaldehyde Residual Purify yeast protein Sodium chloride 4.5 mg Adjust tonicity Sodium borate 35 μg Buffer Water for injection Solvent Vaccine ingredients Fact sheet August 2017 page 5 Hiberix Vaccine against Haemophilus influenzae type b (Hib) disease Type: Subunit, polysaccharide conjugate vaccine Ingredients Quantity/dose (0.5ml) Function Active substances Haemophilus influenzae type b (Hib) polysaccharide, conjugated to tetanus toxoid 10 μg Approximately 25 μg Antigen Carrier protein Excipients Culture media including bovine derived material Residual Grow Haemophilus influenzae type b (Hib) and Clostridium tetani (tetanus) Formaldehyde ≤ 0.5 μg Inactivating agent Lactose 12.6 mg Stabiliser Sodium chloride 0.9% Diluent Infanrix-hexa Vaccine against diphtheria, tetanus, pertussis, polio, hepatitis B, Haemophilus influenzae type b (Hib) diseases Type: Subunit, toxoid, inactivated protein, inactivated virus, recombinant protein and polysaccharide conjugate vaccine Ingredients Quantity/dose (0.5mL) Function Active substances Diphtheria toxoid, adsorbed Not less than 30 IU (25 Lf U) Antigen Tetanus toxoid, adsorbed Not less than 40 IU (10 Lf U) Antigen Pertussis toxoid, adsorbed 25 μg Antigen Filamentous haemagglutinin, adsorbed 25 μg Antigen Pertactin, (69 kiloDalton outer membrane protein) 8 μg Antigen r-Hepatitis B surface antigen, adsorbed (HBsAg) 10 μg Antigen Inactivated Polio Virus Type 1 40 DU Antigen Inactivated Polio Virus Type 2 8 DU Antigen Inactivated Polio Virus Type 3 32 DU Antigen Haemophilus influenzae type b capsular polysaccharide, conjugated to tetanus toxoid 10 μg 20–40 μg Antigen Carrier protein Adjuvants Aluminium as aluminium hydroxide and aluminium phosphate 0.5 mg 0.32 mg Adjuvant Excipients Culture media including medium 199, bovine derived material Residual Grow Clostridium tetani (tetanus), Corynebacterium diphtheriae (diphtheria), Bordetella pertussis (pertussis); stabilise polio viruses Formaldehyde Residual Inactivating agent Potassium chloride, sodium chloride, disodium phosphate Adjust tonicity Monopotassium phosphate Residual Buffer Glycine, lactose Stabiliser Polysorbate 20, polysorbate 80 Surfactant Neomycin, polymyxin B Residual Antibacterial Water for injection Solvent Vaccine ingredients IPOL Vaccine against polio disease Type: Inactivated virus vaccine Ingredients Quantity/dose (0.5mL) Function Active substances Inactivated Polio virus type 1 (Mahoney) 40 DU Antigen Inactivated Polio virus type 2 (MEF-1) 8 DU Antigen Inactivated Polio virus type 3 (Saukett) 32 DU Antigen Excipients Culture media including medium 199 hanks, bovine derived material Residual Grow polio viruses Formaldehyde 2–20 μg Inactivating agent Sodium chloride Residual Adjust tonicity Hydrochloric acid or sodium hydroxide Buffer Polysorbate 80 Residual Surfactant Neomycin, polymyxin B, streptomycin Residual Antibacterial 2-phenoxyethanol 2–3 μL Preservative Water for injection Solvent Infanrix-IPV Vaccine against diphtheria, tetanus, pertussis and polio diseases Type: Subunit, toxoid, inactivated protein and inactivated virus vaccine Ingredients Quantity/dose (0.5mL) Function Active substances Diphtheria toxoid, adsorbed Not less than 30 IU (25 Lf U) Antigen Tetanus toxoid, adsorbed Not less than 40 IU (10 Lf U) Antigen Pertussis toxoid, adsorbed 25 μg Antigen Filamentous haemagglutinin, adsorbed 25 μg Antigen Pertactin, (69 kiloDalton outer membrane protein) 8 μg Antigen Inactivated Polio Virus Type 1 40 DU Antigen Inactivated Polio Virus Type 2 8 DU Antigen Inactivated Polio Virus Type 3 32 DU Antigen Adjuvants Aluminium hydroxide Less than 0.625 mg by assay Adjuvant Excipients Culture media including medium 199, bovine derived material Residual Grow Clostridium tetani (tetanus), Corynebacterium diphtheriae (diphtheria), Bordetella pertussis (pertussis); stabilise polio viruses Formaldehyde Residual Inactivating agent Potassium chloride, disodium phosphate Sodium chloride Residual Adjust tonicity Monopotassium phosphate Residual Buffer Glycine Residual Stabiliser Polysorbate 80 Residual Surfactant Neomycin, polymyxin B Residual Antibacterial Water for injection Solvent Fact sheet August 2017 page 6 Vaccine ingredients Prevenar 13 Vaccine against pneumococcal disease (13-valent) Type: Subunit, polysaccharide conjugate vaccine Ingredients Quantity/dose (0.5mL) Function Active substances Pneumococcal polysaccharide serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C,19A, 19F, 23F 2.2 μg Antigen Pneumococcal polysaccharide serotype 6B 4.4 μg Antigen All conjugated to diphtheria CRM197 34 μg Carrier protein Adjuvants Aluminium as aluminium phosphate 0.565 mg Adjuvant Excipients Culture media Residual Grow Streptococcus pneumoniae (pneumococcal) and Corynebacterium diphtheria (diphtheria) Sodium chloride Residual Adjust tonicity Succinic acid 295 μg Buffer Polysorbate 80 100 μg Surfactant Water for injection Solvent M-M-R II Vaccine against measles, mumps and rubella diseases Type: Live attenuated virus vaccine Ingredients Quantity/dose (0.5mL) Function Active substances Attenuated Enders’ attenuated Edmonston measles virus Not less than 1,000 CCID50 Antigen Attenuated Jeryl Lynn (B Level) mumps virus Not less than 12,500 CCID50 Antigen Attenuated Wistar RA 27/3 rubella virus Not less than 1,000 CCID50 Antigen Excipients Culture media including medium 199, minimum essential medium, bovine derived material Residual Grow measles, mumps and rubella viruses ‘Other ingredients’ not specified Residual Components of growth media; buffer Sodium chloride Residual Adjust tonicity Sodium phosphate Buffer Hydrolised gelatin, recombinant human albumin, sorbitol, sucrose 14.5 mg, ≤ 0.3 mg, 14.5 mg, 1.9 mg Stabiliser Neomycin Residual Antibacterial Water for injection Diluent Fact sheet August 2017 page 7 Priorix Vaccine against measles, mumps and rubella diseases Type: Live attenuated virus vaccine Ingredients Quantity/dose (0.5mL) Function Active substances Attenuated Schwartz measles virus Not less than 103.0 CCID50 Antigen Attenuated RIT 4385 (derived from Jeryl Lynn) mumps virus Not less than 103.7 CCID50 Antigen Attenuated Wistar RA 27/3 rubella virus Not less than 103.0 CCID50 Antigen Excipients Culture media including amino acids, bovine derived material Residual Grow measles, mumps and rubella viruses Hydrolised gelatin, lactose, mannitol, sorbitol Stabiliser Neomycin Residual Antibacterial Water for injection Diluent Vaccine ingredients Rotarix Vaccine against rotavirus disease Type: Live attenuated virus vaccine Ingredients Quantity/dose (1.5mL) Function Active substances Attenuated RIX 4414 strain of human rotavirus of the G1P[8] type 106.0 CCID50 Antigen Excipients Culture media including dulbecco’s modified eagle medium, bovine and porcine derived material Residual Grow rotaviruses DNA from porcine circoviruses 1 Fragments From porcine-derived material used during manufacture Disodium adipate Buffer Sucrose Stabiliser Water for injection Solvent RotaTeq Vaccine against rotavirus disease Type: Live attenuated virus vaccine Ingredients Quantity/dose (2mL) Function Active substances Live reassortant rotaviruses G1, G3 2.2 x 106 infectious units each Antigen Live reassortant rotavirus G2 2.8 x 106 infectious units Antigen Live reassortant rotavirus G4 2.0 x 106 infectious units Antigen Live reassortant rotavirus P1A[8] 2.3 x 106 infectious units Antigen Excipients Culture media including bovine and porcine derived material Residual Grow rotaviruses DNA from porcine circoviruses 1 and 2 Fragments From porcine-derived material used during manufacture Sodium citrate, sodium hydroxide, sodium phosphate monobasic monohydrate Buffer Sucrose Stabiliser Polysorbate 80 Surfactant Fact sheet August 2017 page 8 Synflorix Vaccine against pneumococcal disease (10-valent) Type: Subunit, polysaccharide conjugate vaccine Ingredients Quantity/dose (0.5mL) Function Active substances Pneumococcal polysaccharide serotypes 1, 5, 6B, 7F, 9V, 14, 23F † 1 μg each Antigen Pneumococcal polysaccharide serotype 4 † 3 μg Antigen Pneumococcal polysaccharide serotype 18C † † 3 μg Antigen Pneumococcal polysaccharide serotype 19F † † † 3 μg Antigen Conjugated to: † Protein D (derived from non-typeable Haemophilus influenzae) 9–16 μg Carrier protein † † Tetanus toxoid 5–10 μg Carrier protein † † † Diphtheria toxoid 3–6 μg Carrier protein Adjuvants Aluminium as aluminium phosphate 0.5 mg Adjuvant Excipients Culture media Residual Grow streptococcus pneumoniae (pneumococcal), Corynebacterium diphtheria (diphtheria), Haemophilus influenzae and Clostridium tetani (tetanus) Sodium chloride 4.3 mg Adjust tonicity Water for injection Solvent Vaccine ingredients Varilrix (human albumin-free) Vaccine against varicella (chickenpox) disease Type: Live attenuated virus vaccine Ingredients Quantity/dose (0.5ml) Function Active substances Attenuated Oka strain varicella-zoster virus 103.3 PFU Antigen Excipients Culture media including amino acids , fetal bovine serum Residual Grow varicella-zoster virus Lactose, mannitol, sorbitol Stabiliser Neomycin Residual Antibacterial Water for injection Diluent

 

(Visited 173 times)

Live Comment

Your email address will not be published.